Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 4
1997 2
1998 2
1999 2
2000 1
2001 3
2002 3
2003 2
2004 2
2005 2
2006 3
2007 1
2009 3
2010 3
2011 5
2012 3
2013 2
2014 2
2015 3
2016 1
2017 2
2018 2
2019 2
2020 5
2021 3
2022 7
2023 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Surfing the insulin signaling web.
Van Obberghen E, Baron V, Delahaye L, Emanuelli B, Filippa N, Giorgetti-Peraldi S, Lebrun P, Mothe-Satney I, Peraldi P, Rocchi S, Sawka-Verhelle D, Tartare-Deckert S, Giudicelli J. Van Obberghen E, et al. Among authors: tartare deckert s. Eur J Clin Invest. 2001 Nov;31(11):966-77. doi: 10.1046/j.1365-2362.2001.00896.x. Eur J Clin Invest. 2001. PMID: 11737239 Review.
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.
Shoji KF, Bayet E, Leverrier-Penna S, Le Devedec D, Mallavialle A, Marionneau-Lambot S, Rambow F, Perret R, Joussaume A, Viel R, Fautrel A, Khammari A, Constantin B, Tartare-Deckert S, Penna A. Shoji KF, et al. Among authors: tartare deckert s. EMBO Rep. 2023 Apr 5;24(4):e55069. doi: 10.15252/embr.202255069. Epub 2023 Feb 6. EMBO Rep. 2023. PMID: 36744297 Free PMC article.
Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.
Sala M, Allain N, Moreau M, Jabouille A, Henriet E, Abou-Hammoud A, Uguen A, Di-Tommaso S, Dourthe C, Raymond AA, Dupuy JW, Gerard E, Dugot-Senant N, Rousseau B, Merlio JP, Pham-Ledart A, Vergier B, Tartare-Deckert S, Moreau V, Saltel F. Sala M, et al. Among authors: tartare deckert s. Oncogene. 2022 Apr;41(18):2571-2586. doi: 10.1038/s41388-022-02266-1. Epub 2022 Mar 23. Oncogene. 2022. PMID: 35322197
[Melanoma therapeutic escape: the biomechanical track].
Lecacheur M, Girard CA, Deckert M, Tartare-Deckert S. Lecacheur M, et al. Among authors: tartare deckert s. Med Sci (Paris). 2020 Nov;36(11):961-965. doi: 10.1051/medsci/2020201. Epub 2020 Nov 5. Med Sci (Paris). 2020. PMID: 33151853 Free article. French. No abstract available.
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma.
Berestjuk I, Lecacheur M, Carminati A, Diazzi S, Rovera C, Prod'homme V, Ohanna M, Popovic A, Mallavialle A, Larbret F, Pisano S, Audebert S, Passeron T, Gaggioli C, Girard CA, Deckert M, Tartare-Deckert S. Berestjuk I, et al. Among authors: tartare deckert s. EMBO Mol Med. 2022 Feb 7;14(2):e11814. doi: 10.15252/emmm.201911814. Epub 2021 Dec 27. EMBO Mol Med. 2022. PMID: 34957688 Free PMC article.
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.
Imbert C, Montfort A, Fraisse M, Marcheteau E, Gilhodes J, Martin E, Bertrand F, Marcellin M, Burlet-Schiltz O, Peredo AG, Garcia V, Carpentier S, Tartare-Deckert S, Brousset P, Rochaix P, Puisset F, Filleron T, Meyer N, Lamant L, Levade T, Ségui B, Andrieu-Abadie N, Colacios C. Imbert C, et al. Among authors: tartare deckert s. Nat Commun. 2020 Jan 23;11(1):437. doi: 10.1038/s41467-019-14218-7. Nat Commun. 2020. PMID: 31974367 Free PMC article.
65 results